Aster DM Quality Care share price
NSE: ASTERDMBSE: 540975Healthcare ServicesMid Cap
Aster DM Quality Care Limited · Formerly Aster DM Healthcare · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Feb 2018 · Issue price ₹190
Last close ₹669.45up ₹6.65 (1.00%)BSE ₹669.65
Share price at the NSE close on 28 Oct 2026. Previous close ₹662.80.
28 Oct: open ₹660.00, high ₹678.15, low ₹652.40
52-week range of traded prices to 28 Oct 2026
₹519.10Low, 4 Feb 2026₹891.30High, 10 Aug 2026
- Next results date: the board meets on 6 Nov 2026 to consider: financial results. The notice · Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹58,354 Cr244th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 183.11
- P/E without one-offsPrice to earnings without one-off items. Market cap divided by core profit: the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, less one-off items (exceptional items and the result of businesses sold or closed). Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes −₹143 crore of one-off items, the largest of them in the quarter to Jun 2026.
- 126.48
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- Shares changed
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.45%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 8.0%
- ROE without one-offsReturn on equity without one-off items. Core profit, the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders less one-off items (exceptional items and the result of businesses sold or closed), as a percentage of the same net worth as the return on equity. Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes −₹143 crore of one-off items, the largest of them in the quarter to Jun 2026.
- 11.5%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 12.4%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.15
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 3,54,57944.4% delivered
About Aster DM Quality Care
Aster DM Quality Care Limited runs hospitals, clinics and diagnostic labs.12 Its hospitals give primary, secondary, tertiary and quaternary care, from everyday treatment to specialist and highly complex procedures, to patients mainly in South and Central India and also in Bangladesh.234
It runs 39 hospitals in 28 cities under the Aster DM, CARE Hospitals, Evercare and KIMSHEALTH brands.5 Its Aster Labs business runs laboratories and patient experience centres across South India, and pharmacies run by Alfaone Retail Pharmacies carry the Aster brand under licence.67
The business began in 1987 as a single doctor's clinic in Dubai and started in India in 2001 at MIMS Kozhikode.8 The company was incorporated in 2008 and listed on NSE and BSE in 2018.98 In 2024 it separated its business in the Gulf countries (GCC) from India, and it has since sold the GCC business.810 Quality Care India Limited, which owned CARE Hospitals, KIMSHEALTH and Evercare, merged into the company on 1 Jul 2026, its shareholders receiving 977 shares for every 1,000 they held.111
Its promoters, Azad Moopen and his family and Blackstone, which had backed Quality Care, held 54% of the shares on 31 Jul 2026.1213 Azad Moopen, who founded the business, is Executive Chairman, and Varun Khanna, previously Group Managing Director of Quality Care, is Managing Director and Group CEO.14
Aster DM Quality Care key points
Results
- In the quarter to Jun 2026, on a proforma, unaudited basis (both companies counted as if merged), revenue rose 20% to ₹2,597 crore and operating EBITDA (profit before interest, tax, depreciation and amortisation, as the company adjusts it) rose 30% to ₹576 crore.1516
- For the Aster business alone, revenue rose 22% to ₹1,311 crore, operating EBITDA 29% to ₹277 crore and normalised profit after tax for shareholders (leaving out one-time items) 39% to ₹125 crore in the quarter to Jun 2026.1718
- In the year to Mar 2026, on the same proforma, unaudited basis, revenue rose 14% to ₹9,273 crore and operating EBITDA 21% to ₹2,013 crore, a margin of 21.7%; both growth rates assume constant exchange rates.1920
- In its consolidated accounts for the year to Mar 2026, before the merger, the company reported revenue of ₹4,643 crore, up 12%, operating EBITDA of ₹947 crore, up 17%, and profit after tax for shareholders of ₹388 crore, up 26%.21
Revenue mix
- Hospital and clinic revenue by who pays22
Item quarter to Jun 2026 quarter to Jun 2025 Patients paying themselves (walk-in) 53% 56% Companies and insurers 34% 33% Government health schemes 9% 8% Patients from abroad (medical value travel) 4% 3% - Hospital and clinic revenue by specialty23
Item quarter to Jun 2026 quarter to Jun 2025 Cardiac sciences 15% 16% Neurosciences 11% 11% Oncology (cancer) 10% 10% Orthopaedics 10% 9% Gastroenterology 10% 10% Nephrology (kidney) 6% 6% Other specialties 38% 38%
Where revenue comes from
- Share of hospital and clinic revenue by city, both companies combined24The top 10 cities brought in 78% of this revenue.
Item year to Mar 2026 Bengaluru 15% Trivandrum 12% Kochi 11% Hyderabad 11% Dhaka, Bangladesh 8% Calicut 7%
Hospitals and patients
- On 30 Jun 2026 the group had 10,898 capacity beds; 65% were in Tier 2 and Tier 3 cities.25
- On the proforma basis, the group treated over 2 million patients in the quarter to Jun 2026, up 13%, and blended occupancy (the share of beds in use) rose 510 basis points (hundredths of a percentage point) to 64%, on 10,559 operational beds.2627
- Aster MIMS Kasargod, opened in October 2025, reached EBITDA breakeven (earnings covering its operating costs) in June 2026, within 9 months.2728
- Procedures in the year to Jun 2026, both companies combined29
Item year to Jun 2026 Cardiac procedures 87,125+ Neuro procedures 11,685+ Joint procedures 9,215+ Robotic surgeries 4,780+ Transplants (kidney, liver and heart) 885+
Debt and credit ratings
- Combined net debt (borrowings less cash) was ₹1,162 crore on 30 Jun 2026: the Aster business held net cash of ₹511 crore and Quality Care had debt of ₹1,673 crore.30
- On 10 Jul 2026 ICRA raised its credit rating (a grade of how likely a borrower is to repay) on ₹1,607 crore of term loans to AA, with a stable outlook, from A+.31
- On 30 Jul 2026 CRISIL assigned AA+ with a stable outlook to the long-term and A1+ to the short-term bank facilities, ₹860.50 crore in all, moved over from Quality Care India in the merger.3233
Expansion and capital spending
- The company stated in its annual report for the year to Mar 2026 that it plans to add 4,179 beds, taking capacity to 15,077, with 634 due in the year to Mar 2027 and 53% in existing hospitals.34
- On its earnings call of 5 Aug 2026, the company said it expects to open Aster Capital in Trivandrum (454 beds) around January 2027 and, if medical equipment ordering goes as planned, the 300-bed Aster hospital in Hyderabad around April 2027.3536
- In its exchange filing of 2 Jul 2026, the company said it plans to add 12 LINAC radiation machines in Tier 2 and Tier 3 cities and to invest in 10 robotic surgery platforms and Gamma Knife (radiation-based brain surgery).37
What the company expects
- On its earnings call of 5 Aug 2026, the company said it expects its EBITDA margin (EBITDA as a share of revenue) to reach 24% to 25% within 2 to 3 years of the merger, somewhere between 2028 and 2029.383940
- On its earnings call of 5 Aug 2026, the company said it aims to drive merger synergies (savings and added revenue from combining the businesses) of ₹150 crore to ₹200 crore.41
- On its earnings call of 5 Aug 2026, the company said it expects revenue from patients who travel from abroad for treatment to keep growing by more than 50%, taking its share of revenue to mid-single digits and later double digits.42
Recent events
- On 2 Sep 2026 Union (Mauritius) Holdings, owned by Azad Moopen's family, bought 46.09 lakh shares (about 0.57%) from Centella Mauritius Holdings for about ₹350.34 crore, raising the family's holding to about 24.58%.43
- A subsidiary bought 14.21% of STS Holdings, a Bangladesh company in healthcare services and training, for $44,114,339, the company said on 28 Aug 2026.4445
Last updated
All 45 sources, each with its page
- 1. Annual report, 5 Sep 2026, page 16
- 2. Annual report, 5 Sep 2026, page 4
- 3. Annual report, 5 Sep 2026, page 13
- 4. Annual report, 5 Sep 2026, page 14
- 5. Annual report, 5 Sep 2026, page 57
- 6. Annual report, 5 Sep 2026, page 23
- 7. Annual report, 5 Sep 2026, page 22
- 8. Annual report, 5 Sep 2026, page 11
- 9. Annual report, 5 Sep 2026, page 132
- 10. Annual report, 5 Sep 2026, page 24
- 11. Annual report, 5 Sep 2026, page 7
- 12. Annual report, 5 Sep 2026, page 58
- 13. Exchange filing, 4 Sep 2026, page 1
- 14. Annual report, 5 Sep 2026, page 6
- 15. Investor presentation, 5 Aug 2026, page 7
- 16. Investor presentation, 5 Aug 2026, page 8
- 17. Investor presentation, 5 Aug 2026, page 21
- 18. Investor presentation, 5 Aug 2026, page 23
- 19. Annual report, 5 Sep 2026, page 17
- 20. Annual report, 5 Sep 2026, page 16
- 21. Annual report, 5 Sep 2026, page 24
- 22. Investor presentation, 5 Aug 2026, page 11
- 23. Investor presentation, 5 Aug 2026, page 11
- 24. Annual report, 5 Sep 2026, page 15
- 25. Investor presentation, 5 Aug 2026, page 5
- 26. Earnings call, 5 Aug 2026, page 5
- 27. Investor presentation, 5 Aug 2026, page 7
- 28. Annual report, 5 Sep 2026, page 27
- 29. Investor presentation, 5 Aug 2026, page 12
- 30. Earnings call, 5 Aug 2026, page 7
- 31. Annual report, 5 Sep 2026, page 123
- 32. Exchange filing, 30 Jul 2026, page 1
- 33. Exchange filing, 30 Jul 2026, page 1
- 34. Annual report, 5 Sep 2026, page 15
- 35. Earnings call, 5 Aug 2026, page 16
- 36. Annual report, 5 Sep 2026, page 28
- 37. Exchange filing, 2 Jul 2026, page 3
- 38. Earnings call, 5 Aug 2026, page 9
- 39. Earnings call, 5 Aug 2026, page 15
- 40. Earnings call, 5 Aug 2026, page 18
- 41. Earnings call, 5 Aug 2026, page 19
- 42. Earnings call, 5 Aug 2026, page 18
- 43. Exchange filing, 4 Sep 2026, page 2
- 44. Exchange filing, 28 Aug 2026, page 2
- 45. Exchange filing, 28 Aug 2026, page 3
Results
Consolidated; ₹ crore.Aster DM Quality Care quarterly results
- Revenue growth, 12 monthsRevenue growth, 12 months. The last twelve months against the twelve before them. Left empty where the earlier figure was nought or a loss: growth out of a loss has no percentage.
- +15.7%
- Net profit growth, 12 monthsNet profit growth, 12 months. The last twelve months against the twelve before them. Left empty where the earlier figure was nought or a loss: growth out of a loss has no percentage.
- +0.2%
Quarter to Jun 2026, against the quarter before
- RevenueRevenue. The pill is the change in revenue against the quarter before: this period's figure divided by that one's, less one, in per cent.
- ₹1,311 Crup 10.85%
- Net profitNet profit. The pill is the change in net profit against the quarter before: this period's figure divided by that one's, less one, in per cent. Net profit in the glossary
- ₹29 Crdown 80.94%
- Net marginNet margin. Net profit as a percentage of revenue: how much of each rupee of sales is left after every cost, interest and tax. Net margin in the glossary
- 2.2%
Revenue by quarter
Peak revenue ₹1,311 Cr, quarter to Jun 2026; lowest ₹1,000 Cr, quarter to Mar 2025
Net profit by quarter, a loss in red
| ₹ crore | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 1,086 | 1,050 | 1,000 | 1,078 | 1,197 | 1,186 | 1,182 | 1,311 |
| Net profit | 106 | 64 | 86 | 94 | 121 | 59 | 154 | 29 |
| Net margin | 9.7% | 6.1% | 8.6% | 8.7% | 10.1% | 4.9% | 13.0% | 2.2% |
Consolidated. The last eight quarters. The latest is shaded. Net profit is the whole group's, the other owners of its subsidiaries included; P/E and ROE use the company's own share.
Year to Mar 2026, against the year before
- RevenueRevenue. The pill is the change in revenue against the year before: this period's figure divided by that one's, less one, in per cent.
- ₹4,643 Crup 12.20%
- Net profitNet profit. The pill is the change in net profit against the year before: this period's figure divided by that one's, less one, in per cent.
- ₹427 Crdown 92.10%
- Net margin
- 9.2%
Revenue by year
Net profit by year, a loss in red
The years either side of a change of basis do not compare. From the year to Mar 2024, the company's revenue for that year, ₹3,699 Cr, differs from its quarters added, ₹11,216 Cr. From the year to Mar 2025, the company reports a discontinued business.
| ₹ crore | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 6,721 | 7,963 | 8,739 | 8,608 | 10,253 | 11,933 | 3,699 | 4,138 | 4,643 |
| Net profit | 282 | 367 | 315 | 178 | 601 | 475 | 212 | 5,408 | 427 |
| Net margin | 4.2% | 4.6% | 3.6% | 2.1% | 5.9% | 4.0% | 5.7% | – | 9.2% |
Consolidated. Years to March. The latest is shaded. Net profit is the whole group's, the other owners of its subsidiaries included; P/E and ROE use the company's own share. Net margin is left blank for Mar 2025: the profit includes the result of a business the company has discontinued, which the revenue does not, so the two make no margin.
Business segments
Share of revenue, year to Mar 2026, consolidated.Segment revenue and profit
- Hospitals & ClinicsHospitals & Clinics, share of revenue. The segment's revenue as a percentage of the revenue of all the company's reported business segments together, leaving out eliminations between them and unallocated items.₹4,506 Cr94.2%
- LabsLabs, share of revenue. The segment's revenue as a percentage of the revenue of all the company's reported business segments together, leaving out eliminations between them and unallocated items.₹154 Cr3.2%
- Wholesale PharmaciesWholesale Pharmacies, share of revenue. The segment's revenue as a percentage of the revenue of all the company's reported business segments together, leaving out eliminations between them and unallocated items.₹108 Crdown 14.52%2.3%
- OthersOthers, share of revenue. The segment's revenue as a percentage of the revenue of all the company's reported business segments together, leaving out eliminations between them and unallocated items.₹15 Cr0.3%
The pill is the change in revenue on the year before; the share is of all the businesses together.
Valuation
Today, against the company's own history. Not shown, P/B: the share count changed after the latest balance sheet (a rights issue, a buyback, an allotment or a listing), which does not yet hold the money it brought or returned. Its history crosses a change of basis in the accounts in the years to Mar 2024 and Mar 2025: days before it are of the company before the change.Aster DM Quality Care PE ratio and valuation
Price to earnings
At or below today's level on 97% of 1,908 trading days since Feb 2019.
LowestHighest
Its median38.26Industry median42.88
Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price. When a year's dividend goes ex later than the year before's, the yield reads zero for the days between; a run of under 60 such trading days is left out of the yield's medians and percentiles. The ex-date is the day from which a buyer of the share no longer gets the dividend.
At or below today's level on 74% of 2,111 trading days since Apr 2018.
LowestHighest
Its median0.00%Industry median0.24%
Where the return came from
Yearly rates to Mar 2026, per-share figures restated for splits and bonuses.
| Over | Return a year | Earnings growth | Change in P/E | Dividend yield |
|---|---|---|---|---|
| 1 year | +39.0% | −93.0% | +1,887.1% | 0.4% |
| 3 years | +50.9% | −4.1% | +46.7% | 10.3% |
| 5 years | +43.4% | +20.5% | +14.0% | 6.2% |
Return is price growth plus the average dividend yield. Change in P/E is (1 + price growth) / (1 + earnings growth) - 1, so the parts compound rather than add. Earnings growth over 1 year includes one-off items (exceptional items and the result of businesses sold or closed) of more than a tenth of the profit of the year to Mar 2025.
Mutual fund holdings
176 funds disclosed a holding for Sep 2026. What they did in Sep 2026, against each fund's month before. 36 of the 67 funds that added or cut are index funds, ETFs or arbitrage funds: an index fund or ETF holds what its index holds, and an arbitrage fund holds the share against a sale of its future. 1 more fund filed its first portfolio on record, holding it.All 176 funds holding Aster DM Quality Care
- Bought for the first timeBought for the first time. Funds that held it at the month's end and had not held it in any month on record before.
- 36
- AddedAdded. Funds that held more shares than at the end of the month before.
- 45
- CutCut. Funds that held fewer shares than at the end of the month before.
- 22
- Held unchangedHeld unchanged. Funds that held the same number of shares as at the end of the month before.
- 72
- Sold outSold out. Funds that held it at the end of the month before and hold none at this month's end. Sold out in the glossary
- 26
| Fund | |||
|---|---|---|---|
 HDFC Small Cap FundHDFC Mutual Fund | 1,97,40,031 | 3.37% | ₹1,376.2 Cr |
 Kotak Mid Cap FundKotak Mahindra Mutual Fund | 1,47,13,790 | 1.54% | ₹1,025.8 Cr |
| HDFC Mid Cap FundHDFC Mutual Fund | 1,31,27,998 | 0.90% | ₹915.2 Cr |
| HDFC Focused FundHDFC Mutual Fund | 1,25,65,281 | 3.30% | ₹876.0 Cr |
| HDFC Flexi Cap FundHDFC Mutual Fund | 1,22,34,330 | 0.79% | ₹852.9 Cr |
| Kotak-Small Cap FundKotak Mahindra Mutual Fund | 1,11,67,820 | 4.07% | ₹778.6 Cr |
 quant Small Cap Fundquant Mutual Fund | 1,06,73,152 | 2.09% | ₹744.1 Cr |
 SBI Contra FundSBI Mutual Fund | 91,99,605 | 1.42% | ₹641.4 Cr |
 Nippon India Small Cap FundNippon India Mutual Fund | 87,72,707 | 0.76% | ₹611.6 Cr |
| Kotak Large & Mid Cap FundKotak Mahindra Mutual Fund | 46,00,000 | 1.05% | ₹320.7 Cr |
Portfolios disclosed for Sep 2026. Weight is the holding as a share of the fund's assets.
Promoter and insider buying and selling
Trades made since 29 Oct 2025.Aster DM Quality Care insider trading
Bought on the marketBought on the market. The value each filer stated for its purchases on the exchange, added up; gifts, transfers and pledges are not counted. A purchase filed with no value is counted under the sum, not in it. Sold on the marketSold on the market. The value each filer stated for its sales on the exchange, added up; gifts, transfers and pledges are not counted. A sale filed with no value is counted under the sum, not in it.
- Promoters and promoter group3 purchases, 0 sales₹380 CrNo saleNetNet. The value bought on the market less the value sold, over the trades whose filers stated a value.₹380 Cr3 pledge filings of unclear kind
- Others: no market trade · 8 pledge filings of unclear kind
Bought and sold count trades on the market only. A pledge is shares given to a lender as security for a loan; a lender invokes it by selling them.
Aster DM Quality Care competitors and peers
Hospital, 40 listed companies, priced on 28 Oct 2026. The table lists the 8 companies closest to Aster DM Quality Care in market cap.Healthcare companies
Where the company sits among the companies nearest its size
| Company | ||||||||
|---|---|---|---|---|---|---|---|---|
 Apollo Hospitals EnterpriseAPOLLOHOSP | 1,16,998 | 55.99 | 12.34 | +17.2% | +32.8% | 23.6% | 19.9% | 0.25% |
| Manipal Health EnterprisesMANIPALHOS | 84,612 | – | – | – | – | – | – | 0.00% |
 Max Healthcare InstituteMAXHEALTH | 82,877 | 56.87 | 7.71 | +16.0% | +27.0% | 14.5% | 13.0% | 0.23% |
 Fortis HealthcareFORTIS | 57,339 | 54.72 | 5.79 | +17.5% | +20.7% | 11.1% | 12.7% | 0.13% |
 Narayana HrudayalayaNH | 35,213 | 43.15 | 7.76 | +57.8% | +3.9% | 20.0% | 13.1% | 0.26% |
 Global HealthMEDANTA | 34,497 | 62.02 | 8.71 | +21.3% | +4.1% | 15.1% | 14.2% | 0.04% |
 Krishna Institute of Medical SciencesKIMS | 29,594 | 144.71 | 13.17 | +30.9% | −46.2% | 9.3% | 8.7% | 0.00% |
 Dr. Agarwal's Health CareAGARWALEYE | 15,063 | 101.53 | 7.44 | – | – | 7.6% | 14.1% | 0.00% |
Market cap in ₹ crore. Growth is the last twelve months against the twelve before. A figure is left empty where it would rest on a loss or the company has under a year of results on record. ROE is the shareholders' profit over their net worth. ROCE is profit before interest and tax over the whole group's net worth plus borrowings, as in the figures at the top of the page.
Dividends
Per share, by the year it was paid for, and the latest payments.Aster DM Quality Care dividend history
Dividend per share, ₹, restated for later splits and bonuses
Dividend per share. The dividends declared for the year, each restated to today's share count by the splits and bonuses after its own ex-date, added up. Dividend per share in the glossaryHighest ₹120.00 a share, year to Mar 2024.
| Ex-date | Type | Per share |
|---|---|---|
| 2 Apr 2026 | Interim | ₹3.00 |
| 28 Aug 2025 | FinalFinal dividend. Called final by its date: the company did not say which kind it was, and it went ex within six months after the company's year end, the time in which the annual general meeting that declares the final dividend must be held. Final dividend in the glossary | ₹1.00 |
| 10 Feb 2025 | Interim | ₹4.00 |
| 22 Aug 2024 | Final | ₹2.00 |
| 23 Apr 2024 | Special | ₹118.00 |
Latest payments, as declared, by ex-date.
Latest announcements
Routine notices left out.Aster DM Quality Care announcements
Oct 2026
28 Oct · Board meeting
Sep 2026
28 Sep · Management
Aster DM Quality Care share price by year
Each calendar year to 2025.Aster DM Quality Care share price history
| Year | Close at year end | Change | Highest close | Lowest close |
|---|---|---|---|---|
| 2025 | 616.85 | +20.0% | 722.95 | 394.00 |
| 2024 | 513.95 | +25.4% | 522.75 | 321.75 |
| 2023 | 409.80 | +77.3% | 409.80 | 207.55 |
| 2022 | 231.10 | +33.0% | 269.55 | 161.90 |
| 2021 | 173.80 | +4.8% | 233.85 | 133.20 |
| 2020 | 165.85 | +3.2% | 177.60 | 83.55 |
| 2019 | 160.75 | +3.5% | 165.15 | 112.85 |
| 2018 | 155.30 | – | 191.95 | 141.65 |
₹ per share, adjusted for splits and bonuses since. Change is on the close at the end of the year before. 2018 is from its first session, 26 Feb 2018.
Recent sessions
The 9 trading days to 27 Oct 2026, as traded on NSE; the latest is at the top of the page.
| Date | Open | High | Low | Close | Average price | Volume | Delivery |
|---|---|---|---|---|---|---|---|
| 27 Oct 2026 | 653.30 | 673.90 | 650.00 | 662.80 | 663.90 | 6,93,678 | 43.6% |
| 26 Oct 2026 | 644.50 | 656.25 | 638.75 | 647.00 | 647.21 | 16,79,705 | 74.6% |
| 23 Oct 2026 | 654.05 | 659.70 | 638.00 | 644.75 | 644.05 | 6,45,624 | 53.1% |
| 22 Oct 2026 | 650.05 | 656.55 | 641.80 | 654.70 | 650.99 | 5,23,658 | 45.1% |
| 21 Oct 2026 | 674.50 | 676.80 | 648.70 | 650.15 | 653.13 | 9,28,509 | 73.9% |
| 19 Oct 2026 | 674.40 | 684.85 | 664.80 | 667.15 | 672.70 | 4,13,105 | 53.2% |
| 16 Oct 2026 | 686.50 | 687.95 | 669.35 | 674.35 | 674.15 | 7,03,212 | 55.0% |
| 15 Oct 2026 | 675.20 | 697.30 | 675.20 | 682.65 | 689.19 | 6,19,514 | 49.0% |
| 14 Oct 2026 | 688.10 | 689.55 | 673.60 | 675.20 | 677.94 | 11,27,703 | 66.9% |
Prices in ₹ per share as traded, not adjusted.
Price adjustments
What the price chart is corrected for, so it reads as one share held throughout.Buyback history
| Ex-date | Event | Price factor | What happened |
|---|---|---|---|
| 23 Apr 2024 | Price move | – | A corporate action went ex within three days of this move (Special Dividend - Rs 118 Per Share, ex-date 23 Apr 2024), and its terms do not account for the move. Not adjusted for. |
Each event is noted and not adjusted for.
Company details
- NSE symbol
- ASTERDM
- BSE code
- 540975
- ISIN
- INE914M01019
- Industry
- Healthcare Services
- Website
- www.asterqualitycare.com
- CIN
- L85110TS2008PLC207383
- Corporate identity number, the registrar of companies' code for it
- Incorporated
- 2008
- Registered office
- No. 7-1-450/20, Plot No. 04, Mythri Vihar, Ameerpet, Hyderabad 500038, Telangana
- Share registrar
- MUFG Intime India Pvt. Ltd
- Keeps the register of shareholders and handles transfers and dividend payments
In Nifty 500, BSE 500, Nifty Midcap 150, BSE 250 SmallCap Index, BSE SmallCap, Nifty Total Market